Wu, J.; Wang, S.; Yu, K.; Xu, Z.; Wu, X.; Symmes, D.; Mo, L.; Cheng, C.; Chen, R.; Zhang, J.
Oral Treatment with the Vimentin-Targeting Compound ALD-R491 Mitigates Hyperinflammation, Multi-Organ Injury, and Mortality in CLP-Induced Septic Mice. Life 2025, 15, 1563.
https://doi.org/10.3390/life15101563
AMA Style
Wu J, Wang S, Yu K, Xu Z, Wu X, Symmes D, Mo L, Cheng C, Chen R, Zhang J.
Oral Treatment with the Vimentin-Targeting Compound ALD-R491 Mitigates Hyperinflammation, Multi-Organ Injury, and Mortality in CLP-Induced Septic Mice. Life. 2025; 15(10):1563.
https://doi.org/10.3390/life15101563
Chicago/Turabian Style
Wu, Jianping, Shuaishuai Wang, Kuai Yu, Zijing Xu, Xueting Wu, Deebie Symmes, Lian Mo, Chun Cheng, Ruihuan Chen, and Junfeng Zhang.
2025. "Oral Treatment with the Vimentin-Targeting Compound ALD-R491 Mitigates Hyperinflammation, Multi-Organ Injury, and Mortality in CLP-Induced Septic Mice" Life 15, no. 10: 1563.
https://doi.org/10.3390/life15101563
APA Style
Wu, J., Wang, S., Yu, K., Xu, Z., Wu, X., Symmes, D., Mo, L., Cheng, C., Chen, R., & Zhang, J.
(2025). Oral Treatment with the Vimentin-Targeting Compound ALD-R491 Mitigates Hyperinflammation, Multi-Organ Injury, and Mortality in CLP-Induced Septic Mice. Life, 15(10), 1563.
https://doi.org/10.3390/life15101563
